vs
Nerdy Inc.（NRDY）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Nerdy Inc.的1.4倍（$69.8M vs $49.1M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -18.8%，领先402.9%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 2.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -4.4%）
Nerdy Inc.是总部位于美国的知名教育科技企业，旗下运营Varsity Tutors等在线学习平台，提供一对一实时辅导、点播课程、备考资源及技能培训内容，服务K12学生、高校学习者及职场人士，覆盖多类学业与职业能力提升需求。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NRDY vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.4倍
$49.1M
营收增速更快
RIGL
高出18.9%
2.3%
净利率更高
RIGL
高出402.9%
-18.8%
两年增速更快
RIGL
近两年复合增速
-4.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $49.1M | $69.8M |
| 净利润 | $-9.2M | $268.1M |
| 毛利率 | 51.0% | 91.5% |
| 营业利润率 | -28.3% | 33.2% |
| 净利率 | -18.8% | 384.0% |
| 营收同比 | 2.3% | 21.2% |
| 净利润同比 | 8.9% | 1769.2% |
| 每股收益（稀释后） | $-0.07 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NRDYRIGL
| Q4 25 | $49.1M | $69.8M | ||
| Q3 25 | $37.0M | $69.5M | ||
| Q2 25 | $45.3M | $101.7M | ||
| Q1 25 | $47.6M | $53.3M | ||
| Q4 24 | $48.0M | $57.6M | ||
| Q3 24 | $37.5M | $55.3M | ||
| Q2 24 | $51.0M | $36.8M | ||
| Q1 24 | $53.7M | $29.5M |
净利润NRDYRIGL
| Q4 25 | $-9.2M | $268.1M | ||
| Q3 25 | $-12.3M | $27.9M | ||
| Q2 25 | $-7.9M | $59.6M | ||
| Q1 25 | $-10.5M | $11.4M | ||
| Q4 24 | $-10.1M | $14.3M | ||
| Q3 24 | $-15.9M | $12.4M | ||
| Q2 24 | $-9.1M | $-1.0M | ||
| Q1 24 | $-7.4M | $-8.2M |
毛利率NRDYRIGL
| Q4 25 | 51.0% | 91.5% | ||
| Q3 25 | 62.9% | 93.2% | ||
| Q2 25 | 61.5% | 95.6% | ||
| Q1 25 | 58.0% | 91.7% | ||
| Q4 24 | 66.6% | 89.9% | ||
| Q3 24 | 70.5% | 85.5% | ||
| Q2 24 | 65.7% | 92.4% | ||
| Q1 24 | 68.0% | 93.1% |
营业利润率NRDYRIGL
| Q4 25 | -28.3% | 33.2% | ||
| Q3 25 | -51.5% | 40.9% | ||
| Q2 25 | -27.1% | 60.1% | ||
| Q1 25 | -34.8% | 23.9% | ||
| Q4 24 | -34.0% | 28.9% | ||
| Q3 24 | -68.5% | 25.4% | ||
| Q2 24 | -29.9% | 1.2% | ||
| Q1 24 | -23.9% | -23.6% |
净利率NRDYRIGL
| Q4 25 | -18.8% | 384.0% | ||
| Q3 25 | -33.2% | 40.2% | ||
| Q2 25 | -17.4% | 58.6% | ||
| Q1 25 | -22.1% | 21.5% | ||
| Q4 24 | -21.1% | 24.9% | ||
| Q3 24 | -42.4% | 22.5% | ||
| Q2 24 | -17.8% | -2.8% | ||
| Q1 24 | -13.9% | -27.9% |
每股收益（稀释后）NRDYRIGL
| Q4 25 | $-0.07 | $14.11 | ||
| Q3 25 | $-0.10 | $1.46 | ||
| Q2 25 | $-0.07 | $3.28 | ||
| Q1 25 | $-0.09 | $0.63 | ||
| Q4 24 | $-0.09 | $0.82 | ||
| Q3 24 | $-0.14 | $0.70 | ||
| Q2 24 | $-0.08 | $-0.06 | ||
| Q1 24 | $-0.07 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $47.9M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $19.0M | $391.5M |
| 总资产 | $76.2M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NRDYRIGL
| Q4 25 | $47.9M | $155.0M | ||
| Q3 25 | $32.7M | $137.1M | ||
| Q2 25 | $36.7M | $108.4M | ||
| Q1 25 | $44.9M | $77.1M | ||
| Q4 24 | $52.5M | $77.3M | ||
| Q3 24 | $65.0M | $61.1M | ||
| Q2 24 | $69.8M | $49.1M | ||
| Q1 24 | $77.0M | $49.5M |
总债务NRDYRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益NRDYRIGL
| Q4 25 | $19.0M | $391.5M | ||
| Q3 25 | $24.3M | $117.6M | ||
| Q2 25 | $31.8M | $81.9M | ||
| Q1 25 | $34.4M | $18.6M | ||
| Q4 24 | $39.5M | $3.3M | ||
| Q3 24 | $43.3M | $-14.6M | ||
| Q2 24 | $52.2M | $-29.9M | ||
| Q1 24 | $52.8M | $-31.7M |
总资产NRDYRIGL
| Q4 25 | $76.2M | $513.6M | ||
| Q3 25 | $70.4M | $242.5M | ||
| Q2 25 | $73.7M | $206.7M | ||
| Q1 25 | $83.0M | $176.0M | ||
| Q4 24 | $92.5M | $164.0M | ||
| Q3 24 | $106.8M | $139.4M | ||
| Q2 24 | $111.3M | $128.4M | ||
| Q1 24 | $121.3M | $126.5M |
负债/权益比NRDYRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-4.3M | — |
| 自由现金流率自由现金流/营收 | -8.7% | — |
| 资本支出强度资本支出/营收 | 2.7% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-24.2M | — |
8季度趋势，按日历期对齐
经营现金流NRDYRIGL
| Q4 25 | $-2.9M | $22.0M | ||
| Q3 25 | $-2.4M | $24.0M | ||
| Q2 25 | $-7.0M | $30.5M | ||
| Q1 25 | $-6.4M | $-893.0K | ||
| Q4 24 | $-11.3M | $14.5M | ||
| Q3 24 | $-3.1M | $21.7M | ||
| Q2 24 | $-5.6M | $302.0K | ||
| Q1 24 | $4.4M | $-5.0M |
自由现金流NRDYRIGL
| Q4 25 | $-4.3M | — | ||
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-8.2M | — | ||
| Q1 25 | $-7.6M | — | ||
| Q4 24 | $-12.5M | — | ||
| Q3 24 | $-5.0M | — | ||
| Q2 24 | $-7.1M | — | ||
| Q1 24 | $2.1M | — |
自由现金流率NRDYRIGL
| Q4 25 | -8.7% | — | ||
| Q3 25 | -11.2% | — | ||
| Q2 25 | -18.1% | — | ||
| Q1 25 | -16.0% | — | ||
| Q4 24 | -26.0% | — | ||
| Q3 24 | -13.3% | — | ||
| Q2 24 | -14.0% | — | ||
| Q1 24 | 4.0% | — |
资本支出强度NRDYRIGL
| Q4 25 | 2.7% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 4.1% | — |
现金转化率NRDYRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
